Two‐year outcomes in de novo renal transplant recipients receiving everolimus‐facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study-Reference-Cited by-同舟云学术

Two‐year outcomes in de novo renal transplant recipients receiving everolimus‐facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

Published:2019-07 Issue:11 Volume:19 Page:3018-3034
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Berger Stefan P.¹,Sommerer Claudia²,Witzke Oliver³⁴,Tedesco Helio⁵^ORCID,Chadban Steve⁶,Mulgaonkar Shamkant⁷,Qazi Yasir⁸,Fijter Johan W.⁹,Oppenheimer Federico¹⁰,Cruzado Josep M.¹¹,Watarai Yoshihiko¹²,Massari Pablo¹³,Legendre Christophe¹⁴^ORCID,Citterio Franco¹⁵,Henry Mitchell¹⁶,Srinivas Titte R.¹⁷,Vincenti Flavio¹⁸^ORCID,Gutierrez Maria Pilar Hernandez¹⁹,Marti Ana Maria¹⁹,Bernhardt Peter¹⁹,Pascual Julio²⁰,

Affiliation:

1. Division of Nephrology University of GroningenUniversity Medical Center Groningen Groningen The Netherlands

2. Department of Nephrology Heidelberg University Hospital Heidelberg Germany

3. Department of Infectious Diseases University Hospital EssenUniversity Duisburg‐Essen Essen Germany

4. Department of Nephrology University Hospital EssenUniversity Duisburg‐Essen Essen Germany

5. Nephrology Division Hospital do RimUniversidade Federal de São Paulo (UNIFESP) São Paulo Brazil

6. Department of Renal Medicine and Transplantation Royal Prince Alfred Hospital Camperdown New South Wales Australia

7. Renal and Pancreas DivisionSaint Barnabas Medical CenterLivingston New Jersey

8. Division of Nephrology Keck School of Medicine Renal Transplant Program University of Southern California Los Angeles California

9. LUMC Leids Universitair Medisch Centrum Leiden The Netherlands

10. Department of Nephrology and Renal Transplantation Renal Transplant UnitHospital Clinic of Barcelona Barcelona Spain

11. Hospital Universitari De BellvitgeIDIBELL, Hospitalet de Llobregat Barcelona Spain

12. Department of Transplant Surgery Nagoya Daini Red Cross Hospital Nagoya‐City, Aichi Japan

13. Hospital Privado Centro Medico de Cordoba Cordoba Argentina

14. Department of Kidney Transplantation Adult Transplantation Service Paris Descartes University and Necker Hospital Paris France

15. Agostino Gemelli University Polyclinic FoundationCatholic University of the Sacred Heart Rome Italy

16. Department of Surgery The Comprehensive Transplant CenterThe Ohio State University Wexner Medical Center Columbus Ohio

17. Division of Nephrology Medical University of South Carolina Mount Pleasant South Carolina

18. Department of Surgery Kidney Transplant Service University of California San Francisco California

19. Department of Research and Development Novartis Pharma AG Basel Switzerland

20. Department of Nephrology Hospital del Mar Barcelona Spain

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15480

Reference40 articles.

1. Chronic Calcineurin Inhibitor Nephrotoxicity-Lest We Forget

2. Calcineurin Inhibitor Nephrotoxicity: A Review and Perspective of the Evidence

3. Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network

4. Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens

5. Cyclosporine induces cancer progression by a cell-autonomous mechanism

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Immunosuppression in Kidney Transplant Recipients: An Update for the General Nephrologist;Advances in Kidney Disease and Health;2024-09

3. Betreuung von Patienten nach Nierentransplantation;Nephrologie aktuell;2024-09

4. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

5. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07